Page 10 - Ndpoint Threat Detection And Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ndpoint threat detection and response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ndpoint Threat Detection And Response Today - Breaking & Trending Today

AstraZeneca's Lynparza, Imfinzi Ovarian Cancer Treatment Met Primary Endpoint in Phase 3 Trial

By Joe Hoppe


AstraZeneca PLC said Wednesday that its Lynparza and Imfinzi combination met its endpoint in the treatment of patients with advanced ovarian cancer.

The pharma major said the. | April 5, 2023 ....

Joe Hoppe , Dow Jones , Astrazeneca Plc Stock Exchange , Press Release , Aid Azn Gb0009895292 ,